Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
clinical trials
3
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
biogen
biotech
boston top stories
san francisco blog main
san francisco top stories
sanofi
startups
venture capital
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amgen
amunix
anirvan ghosh
antisense oligonucleotide
astrazeneca
benzodiazepines
blackstone group
blackstone life sciences
bluerock therapeutics
boston
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
cholesterol
columbia university
covid-19
crispr
data
What
ceo
3
×
medicines
announced
aces
acquisitions
aims
backed
big
bio
cause
cholesterol
collabs
covid
daniel
deal
drug
drugs
epilepsy
flexible
genes
genetic
gilead
gilead’s
help
inclisiran
introduce
ipo
key
links
lowering
marcio
meant
medco
medicine
month
mutations
nasdaq
neuro
new
open
Language
unset
3
×
Current search:
ceo
×
unset
×
" clinical trials "
×
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing